#1 Clinical Trials Search in Europe

Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

↓

Matched clinical trials

  • A study to evaluate the effectiveness of epcoritamab in patients with Waldenström’s macroglobulinemia that has returned or has not responded to previous treatments.

    Recruiting

    1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Denmark The Netherlands

  • A Study of Zanubrutinib for Patients with Anti-MAG Antibody Neuropathy Associated with Blood Disorders or Abnormal Protein in the Blood

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Italy

  • Study on Venetoclax and Rituximab for Patients with Waldenström’s Macroglobulinemia

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany Greece

  • Dose optimization study of ibrutinib drug combination in adult patients with haematological diseases

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Denmark

  • Evaluating Sonrotoclax Alone and Combined with Zanubrutinib for Patients with Previously Untreated or Relapsed/Refractory Waldenström Macroglobulinemia

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Greece Italy Spain

  • Long-Term Access to Ibrutinib for Patients with Lymphoma, Leukemia, and Other Conditions

    Not recruiting

    3 1 1
    Investigated Drugs:
    Czechia France Hungary Italy Poland Spain +1

  • Study of CLR 131 for Patients with Relapsed or Refractory Waldenstrom Macroglobulinemia

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Greece Spain

  • Study on Brexucabtagene Autoleucel for Adults with Relapsed/Refractory Waldenstrom Macroglobulinemia Using a Drug Combination

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria France Germany Italy The Netherlands Spain +1

  • Long-Term Safety Study of Venetoclax for Patients with Chronic Lymphocytic Leukemia, Non-Hodgkin’s Lymphoma, Multiple Myeloma, or Acute Leukemia

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Denmark France Greece Ireland Poland +1

  • Study on Carfilzomib and Ibrutinib for Patients with Waldenström’s Macroglobulinemia

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Germany Greece